NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-13 Cr | ₹18 Cr | ₹75 Cr | ₹38 Cr | ₹17 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-13 Cr |
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹17 Cr |
How is Cash Flow from Operating Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-13 Cr | Negative | |
| Mar2025 | ₹18 Cr | -76.43 | |
| Mar2024 | ₹75 Cr | 94.42 | |
| Mar2023 | ₹38 Cr | 125.05 | |
| Mar2022 | ₹17 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹264.0 Cr | -2.8% | -9.2% | -20% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,690.0 Cr | -3.5% | -3.8% | -33.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,386.6 Cr | 3.8% | 1% | 10.7% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,366.8 Cr | -2.7% | -1.9% | 25.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹839.6 Cr | -5% | -9.8% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹525.0 Cr | -1.2% | 10% | -2.8% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -2.8% |
-9.2% |
-20% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses